Price
No data yet.
Social Signal Score
Analyst Ratings
29 analystsRevenue
$1.95B+35.00%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Linda J. Rendle
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Employees
- 9,200
- Beta
- 0.54
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.95
Financials
Revenue
$1.95B+35.0%Net Income
$163.00M-8.9%EBITDA
$99.00M-69.7%Free Cash Flow
$244.00M+119.8%EPS (diluted)
$1.33-2.2%Shares Outstanding (diluted)
122.13M-7.6%Operating Expenses
$-203.00MCash & Debt
$143.00MReturn of Capital
$150.00MRevenue by Segment (annual)
$6.72BDividend per Share
$1.25Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $6.72B | $587.00M | $4.82 |
| 2025 | $7.10B | $810.00M | $6.56 |
| 2024 | $7.09B | $280.00M | $2.25 |
| 2023 | $7.39B | $149.00M | $1.21 |
| 2022 | $7.11B | $462.00M | $3.75 |
| 2021 | $7.34B | $710.00M | $5.65 |
| 2020 | $6.72B | $939.00M | $7.46 |
| 2019 | $6.21B | $820.00M | $6.42 |
| 2018 | $6.12B | $823.00M | $6.37 |
| 2017 | $5.97B | $701.00M | $5.43 |
| 2016 | $5.76B | $648.00M | $5.01 |
| 2015 | $5.66B | $580.00M | $4.45 |
| 2014 | $5.51B | $558.00M | $4.31 |
| 2013 | $5.53B | $572.00M | $4.37 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CLX's reported EPS growth of 0.8% a year over 13 years.
- EPS in 5 years
- $5.02
- Implied price
- $100.33
- Return from $80.41
- 4.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $49.88 — -38.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 14 | 17 | 20 | 23 | 26 |
|---|---|---|---|---|---|
| -9.2% | -12.3% | -8.9% | -5.8% | -3.2% | -0.8% |
| -4.2% | -7.5% | -3.8% | -0.7% | 2.2% | 4.7% |
| 0.8% | -2.7% | 1.2% | 4.5% | 7.5% | 10.2% |
| 5.8% | 2.2% | 6.2% | 9.7% | 12.8% | 15.6% |
| 10.8% | 7.0% | 11.2% | 14.9% | 18.2% | 21.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
128+156.20%Social Signal Score
Mentions (30)
- Newsfool.com·2d ago·Neutral
Clorox, General Mills, and Constellation Brands Are Down Between 22% and 33%. Here's the Stock to Buy, Even if the Fed Keeps Hiking Interest Rates. Clorox and General Mills are still working through company-specific challenges. Constellation's Modelo and Corona brands may help support cash flow while it reduces debt.
View source ↗ - News (Marketaux)insidermonkey.com·3d ago·Positive
Clorox Has Some Great Brands. Is its Stock a Good Value? The Clorox Company[+338 characters]
View source ↗ - Newsfool.com·3d ago·Neutral
Clorox is Dealing With Several Years of Challenging Circumstances Business boomed during the pandemic, but since the economic reopening, it has been one difficulty after another for Clorox (CLX -0.30%).
View source ↗ - Newszacks.com·4d ago·Positive
Will Innovation and Digital Expansion Efforts Drive Clorox's Growth? CLX's innovation, GOJO acquisition and digital transformation are strengthening its health and hygiene portfolio while supporting long-term growth.
View source ↗ - Newszacks.com·4d ago·Negative
Is the Options Market Predicting a Spike in Clorox Stock? Investors need to pay close attention to CLX stock based on the movements in the options market lately.
View source ↗ - Newsseekingalpha.com·7d ago·Negative
Clorox: The 6% Yield & Bargain Valuation Can't Fix A Slow Recovery The Clorox Company (CLX) trades at a depressed 14x forward P/E and offers a 6% dividend yield, but faces ongoing macro and execution headwinds. Despite a brighter FY27 outlook, CLX's near-term organic growth and margin expansion remain challenged by inflation, weak volumes, and integration risks from the GOJO acquisition. I maintain a hold rating, as a turnaround appears at least 12–24 months away, with upside hinging on cost syn…
View source ↗ - Newsprnewswire.com·8d ago·Neutral
The Clorox Company Announces the Official Launch of Clorox Purell ProCare™ The new B2B-focused business, created through the combination of CloroxPro and GOJO, Makers of Purell, brings professional and healthcare customers unparalleled access to the most trusted health and hygiene solutions in the industry. OAKLAND, Calif.
View source ↗ - News247wallst.com·8d ago·Positive
Clorox Just Raised Its Dividend Again. Can Earnings Keep Up? Clorox has raised its dividend for decades, but a cratering stock price, a payout ratio management calls elevated, and a debt load that ballooned after two major deals raise a pointed question about whether that streak survives fiscal 2027.
View source ↗ - News (Marketaux)seekingalpha.com·11d ago·Positive
Clorox Stock: Operations Should Improve Going Forward, But I’ll Be Patient (NYSE:CLX) I wanted to take a look at the [+252 characters]
View source ↗ - Newsseekingalpha.com·11d ago·Negative
Clorox's Selloff May Not Be Over Yet (Rating Downgrade) The Clorox Company's stock price has dropped by roughly 21% in just 1 month. I'm downgrading CLX to a Sell due to persistent financial weakness and lack of turnaround catalysts. CLX reported a 13% organic sales drop and gross margin contraction of 520 basis points, signaling ongoing operational challenges.
View source ↗ - Newsprnewswire.com·12d ago·Negative
Clorox Declares Regular Quarterly Dividend of $1.25 Per Share OAKLAND, Calif., Sept. 23, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.25 per share on the company's common stock.
View source ↗ - Newsseekingalpha.com·14d ago·Negative
Clorox: The Fundamentals Are Deteriorating - The Dividends Won't Save You Clorox is downgraded from hold to sell due to deteriorating fundamentals and unsustainable dividend coverage. Organic sales declined 13% in Q4 despite the GOJO acquisition, with only the international segment showing growth. Long-term debt surged to nearly $4 billion, raising concerns amid a high interest rate environment and declining profitability.
View source ↗ - News247wallst.com·15d ago·Neutral
Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not be sustainable.
View source ↗ - Newszacks.com·18d ago·Positive
ADRNY vs. CLX: Which Stock Should Value Investors Buy Now? Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks presents investors with the better value opportunity right now?
View source ↗ - Newszacks.com·19d ago·Neutral
Will Strategic Initiatives and Pricing Strength Boost Clorox's Growth? CLX's margin management, innovation and IGNITE strategy support growth, while cost pressures and value-conscious consumers challenge its progress.
View source ↗ - News (Marketaux)dividend-growth-stocks.com·25d ago·Neutral
The Clorox Company (CLX) Dividend Stock Analysis The Clorox Company (CLX) Dividend Stock Analysis
View source ↗ - Newsseekingalpha.com·26d ago·Positive
The Clorox Company (CLX) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript The Clorox Company (CLX) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
View source ↗ - News247wallst.com·27d ago·Positive
Passive Income Investors Are Buying 5 Well-Known High-Yield Stocks Near 52-Week Lows When quality dividend stocks drift toward 52-week lows, patient income investors often find their best opportunities hiding in plain sight. Five household names are sitting at beaten-down prices right now, and the yields they are offering demand a closer look.
View source ↗ - Newszacks.com·32d ago·Neutral
Can Cost Savings Offset Inflation & Protect Clorox's Margins? CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.
View source ↗ - Newszacks.com·33d ago·Neutral
Clorox (CLX) Down 9.3% Since Last Earnings Report: Can It Rebound? Clorox (CLX) reported earnings 30 days ago. What's next for the stock?
View source ↗ - 4chan /biz/biz·34d ago·Positive
Should I buy some CLX? I'm looking for a good divvie stock, shill me your tickers, everything is on sale right now
View source ↗ - Newszacks.com·34d ago·Neutral
ADRNY or CLX: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Ahold NV (ADRNY) or Clorox (CLX). But which of these two stocks offers value investors a better bang for their buck right now?
View source ↗ - Newsyoutube.com·40d ago·Positive
3 Cheap Stocks Offering Attractive Income Buy these undervalued dividend stocks that have healthy yields to generate dependable income.
View source ↗ - Newsfool.com·42d ago·Positive
Should Passive Income Investors Buy Clorox Stock? Clorox (CLX +0.45%) could be an interesting stock to consider for dividend investors.
View source ↗ - Newszacks.com·45d ago·Neutral
How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
View source ↗ - Newszacks.com·45d ago·Positive
Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure? CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
View source ↗ - Newszacks.com·45d ago·Neutral
Clorox Stock Jumps 13.1% in a Month. Can the Gains Keep Building? CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
View source ↗ - Newsseekingalpha.com·46d ago·Neutral
Clorox: A Better Business, But Too Much Growth Is Priced In I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns.
View source ↗ - Newsprnewswire.com·47d ago·Neutral
Clorox to Present at Barclays Global Consumer Staples Conference OAKLAND, Calif., Aug. 19, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle and Chief Financial Officer Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Wednesday, September 9, in Boston.
View source ↗ - News (RSS)yahoo·48d ago·Neutral
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $1.09 per share
Typical surprise +3.9% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$1.66 vs $1.64beat
- Thu, Apr 30$1.64 vs $1.55beat
- Tue, Feb 3$1.39 vs $1.43miss
- Mon, Nov 3$0.85 vs $0.82beat
- Thu, Jul 31$2.87 vs $2.20beat
- Mon, May 5$1.45 vs $1.55miss
Estimates and results for CLX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CLX officers and directors.
- Bought
- $846k
- Sold
- —
2 trades
0 trades
- Breber Pierre Rbought
- Breber Pierre Rbought
98 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jun 9, 2026 (25d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jan 12, 2026 (24d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Dec 15, 2025 (33d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (17d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (50d later)Buy$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed May 9, 2025 (28d later)Sell$15,001 - $50,000
- Thomas Hawley Tubervillesenate · AL · disclosed May 15, 2024 (16d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Apr 5, 2024 (16d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (16d later)Sell$15,001 - $50,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (22d later)Buy$100,001 - $250,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (16d later)Sell$100,001 - $250,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (16d later)Sell$50,001 - $100,000
- Thomas Hawley Tubervillesenate · AL · disclosed Nov 16, 2023 (16d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.